PRESCRIBING · PART D · 2024
Total Rx claims
1,251
Beneficiaries
—
Total drug cost
$2.8M
Distinct drugs
28
Brand share
77.9%
Top prescribed drugs
Dolutegravir Sodium/Lamivudine154 claims
Dolutegravir Sodium133 claims
Emtricitabine/Tenofov Alafenam107 claims
Dolutegravir/Rilpivirine89 claims
Doravirine78 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
CROSS-REFERENCE